Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Herbal medicine and nutraceuticals may help treat Post COVID-19 Syndrome, but more research is needed.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

A woman's complete hair loss condition improved after recovering from COVID-19.

Long COVID patients may have hormonal imbalances linked to their symptoms.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Drinking lots of sugary drinks may increase the risk of hair loss in young men.

More research is needed to understand hair and scalp disorders in people with skin of color.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The document is a detailed medical reference on skin and genetic disorders.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document is a detailed guide on skin conditions and treatments for dermatologists.